EVIDENCE-BASED THERAPEUTIC ACTIVITY OF POMEGRANATE AND ITS ACTIVE CONSTITUENT ELLAGIC ACID

被引:0
|
作者
Mansoury, Manal M. S. [1 ]
机构
[1] King Abdulaziz Univ, Fac Home Econ, Dept Food & Nutr, Jeddah, Saudi Arabia
来源
PHARMACOPHORE | 2019年 / 10卷 / 01期
关键词
Pomegranate juice; ellagic acid; therapeutic activity; DOUBLE-BLIND; OXIDATIVE STRESS; ANTIOXIDANT STATUS; LIPID-PEROXIDATION; JUICE CONSUMPTION; DIABETIC-PATIENTS; EXTRACT; POLYPHENOLS; EFFICACY; IMPROVEMENT;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Presently pomegranate is used in traditional medicine for its pharmacological properties. Consumption of fresh vegetables and fruits can improve the human health mainly because of their high contents of beneficial phytochemicals and other micronutrients. Pomegranate has multiple pharmacological activities including anti-inflammatory, antioxidant, and anticancer actions. Ellagic acid is a major compound of pomegranate which is naturally existing in many kinds. It has also been found in raspberries, blackberries, cranberries, strawberries, pecans, walnuts, green tea, pomegranates, and blueberries. Recently, numerous studies have proven the effectiveness of ellagic acid and pomegranate juice in the treatment of prostate cancer, diabetes, melasma, ultraviolet radiation-induced skin damage, endotoxemia, rheumatoid arthritis and osteoarthritis, cardiovascular diseases, blood pressure, hyperlipidemia, erectile dysfunction, dental disorders, diabetes, and idiopathic central precocious puberty. The therapeutic effect of ellagic acid and pomegranate juice could be due to the clinically evidenced antioxidant activities. In conclusion, ellagic acid may be used as a therapy or adjuvant therapy for the treatment of many illnesses. Copyright (c) 2013-All Rights Reserved-Pharmacophore.
引用
收藏
页码:30 / 36
页数:7
相关论文
共 50 条
  • [41] Ellagic acid (EA), a tannin was isolated from Eucalyptus citriodora leaves and its anti-inflammatory activity
    Yu Qiujian
    Feng Zongcai
    Huang Liping
    He Jingwei
    Zhou Zhongliu
    Liu Fang
    MEDICINAL CHEMISTRY RESEARCH, 2021, 30 (12) : 2277 - 2288
  • [42] Evidence-Based Nursing of the 3C Therapeutic Regimen for Type 1 Diabetes
    Jianya Wu
    Ling Zou
    Cell Biochemistry and Biophysics, 2015, 72 : 57 - 60
  • [43] Turoctocog alfa: an evidence-based review of its potential in the treatment of hemophilia A
    Takedani, Hideyuki
    Hirose, Jun
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 1767 - 1772
  • [44] Evidence-Based Nursing of the 3C Therapeutic Regimen for Type 1 Diabetes
    Wu, Jianya
    Zou, Ling
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2015, 72 (01) : 57 - 60
  • [45] Anti-enterovirus 71 activities of Melissa officinalis extract and its biologically active constituent rosmarinic acid
    Chen, Sin-Guang
    Leu, Yann-Lii
    Cheng, Mei-Ling
    Ting, Siew Chin
    Liu, Ching-Chuan
    Wang, Shulhn-Der
    Yang, Cheng-Hung
    Hung, Cheng-Yu
    Sakurai, Hiroaki
    Chen, Kuan-Hsing
    Ho, Hung-Yao
    SCIENTIFIC REPORTS, 2017, 7
  • [46] A Review on Novel Therapeutic Modalities and Evidence-based Drug Treatments against Allergic Rhinitis
    Kumar, Bhupendra
    Deshmukh, Rohitas
    CURRENT PHARMACEUTICAL DESIGN, 2024, 30 (12) : 887 - 901
  • [47] Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review
    Joshi, Shashank R.
    Standl, Eberhard
    Tong, Nanwei
    Shah, Parag
    Kalra, Sanjay
    Rathod, Rahul
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (13) : 1959 - 1981
  • [48] Therapeutic properties of Punica granatum L (pomegranate) and its applications in lung-based diseases: A detailed review
    Shaikh, Sadiya Bi
    Bhandary, Yashodhar Prabhakar
    JOURNAL OF FOOD BIOCHEMISTRY, 2021, 45 (04)
  • [49] An evidence-based review of certolizumab pegol in the treatment of active psoriatic arthritis: place in therapy
    Acosta-Felquer, Maria Laura
    Rosa, Javier
    Soriano, Enrique R.
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2016, 8 : 37 - 44
  • [50] Neuroprotective Potential of Hesperidin as Therapeutic Agent in the Treatment of Brain Disorders: Preclinical Evidence-based Review
    Bansal, Keshav
    Singh, Vanshita
    Singh, Sakshi
    Mishra, Samiksha
    CURRENT MOLECULAR MEDICINE, 2024, 24 (03) : 316 - 326